Novavax Secures EC Approval for Updated 2024-2025 COVID-19 Vaccine
The leading global biotechnology company advancing protein-based vaccines, Novavax, announced that the European Commission has granted Marketing Authorisation for the
Read more
Infectious Diseases
AstraZeneca’s FluMist Influenza Vaccine FDA Approved for Self-Administration
In a landmark approval, the U.S. Food and Drug Administration (FDA) has cleared AstraZeneca’s FluMist, the only influenza vaccine that
Read more
Novavax Wins FDA Emergency Approval for 2024-2025 COVID-19 Vaccine Formula
Novavax, a global leader in protein-based vaccines, has announced that its updated COVID-19 vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705), has received
Read more
FDA Approves Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 Vaccine
Pfizer and BioNTech have announced that the U.S. Food and Drug Administration (FDA) has approved their supplemental Biologics License Application
Read more
imusyn Launches Revolutionary Ready-to-Use T Cell Staining Reagents
Novel T Cell Staining Reagents Now Available at imusyn’s Web Shop imusyn is excited to announce the release of Dyemer
Read more
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-Adapted COVID-19 Vaccine in the EU
Pfizer and BioNTech have received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the
Read more
T Cell Staining Reagents
imusyn’s Dyemer & myDyemer are a pioneering class of ready-to-use and loadable T Cell staining reagents, developed for precise quantification
Read more
Recombinant HLA Proteins
imusyn offers an unmatched portfolio of top-tier recombinant HLA class I and class II proteins, produced as truncated, soluble antigens
Read more
Peptide Binding Analysis
imusyn’s imuPep Class I Peptide Binding Analysis is designed to determine the stability of peptide/HLA class I complexes, allowing researchers
Read more
Encouraging Outcomes for Novel Therapy Targeting Drug-resistant Tuberculosis
Researchers have made a significant leap forward in the fight against drug-resistant tuberculosis (TB), according to a recent study published in
Read more